Health
Gene Therapy Shows Early Promise as Angelman Syndrome Treatment | Newsroom – UNC Health and UNC School of Medicine
Led by Ben Philpot, PhD, and Matt Judson, PhD, the new therapy was generally well-tolerated and prevented key signs of the condition…

Led by Ben Philpot, PhD, and Matt Judson, PhD, the new therapy was generally well-tolerated and prevented key signs of the condition in animal models.
Ben Philpot, PhD
CHAPEL HILL, NC Scientists at the UNC School of Medicine have reported in the journal…
Continue Reading